{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:45:54Z","timestamp":1789173954844,"version":"build-2803163510"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["16K18946"],"award-info":[{"award-number":["16K18946"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18H02588"],"award-info":[{"award-number":["18H02588"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18K06786"],"award-info":[{"award-number":["18K06786"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.bcp.2019.113664","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T18:55:23Z","timestamp":1570733723000},"page":"113664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Clinical prospects of biomarkers for the early detection and\/or prediction of organ injury associated with pharmacotherapy"],"prefix":"10.1016","volume":"170","author":[{"given":"Soichiro","family":"Tajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanae","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3589-5989","authenticated-orcid":false,"given":"Satohiro","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nbt.1625","article-title":"Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium","volume":"28","author":"Dieterle","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.bcp.2019.113664_b0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-0039-1685519","article-title":"Assessment of serious acute and chronic idiosyncratic drug-induced liver injury in clinical practice","volume":"39","author":"Bessone","year":"2019","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0015","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1523-1755.2004.00927.x","article-title":"Spectrum of acute renal failure in the intensive care unit: the PICARD experience","volume":"66","author":"Mehta","year":"2004","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.bcp.2019.113664_b0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1172\/JCI106083","article-title":"Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein","volume":"48","author":"Peterson","year":"1969","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.113664_b0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.taap.2019.01.012","article-title":"A multiplexed UPLC-MS\/MS assay for the simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis","volume":"366","author":"Tengstrand","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2019.113664_b0030","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.transproceed.2016.09.022","article-title":"Urinary clara cell protein in kidney transplant patients: a preliminary study","volume":"48","author":"Garcia-Garcia","year":"2016","journal-title":"Transplant. Proc."},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/icvts\/ivx198","article-title":"Serum beta-2 microglobulin levels for predicting acute kidney injury complicating aortic valve replacement","volume":"25","author":"Zaleska-Kociecka","year":"2017","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"11\u201312","key":"10.1016\/j.bcp.2019.113664_b0040","first-page":"1083","article-title":"Measurement of urinary beta 2-microglobulin in the detection of cisplatin nephrotoxicity","volume":"65","author":"Cohen","year":"1981","journal-title":"Cancer Treat. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2019.113664_b0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00258126","article-title":"Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment?","volume":"14","author":"Sorensen","year":"1985","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0050","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/clpt.1980.79","article-title":"Comparison of methods of evaluating nephrotoxicity of cis-platinum","volume":"27","author":"Jones","year":"1980","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2019.113664_b0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1515\/CCLM.2000.072","article-title":"Probable involvement of cathepsin D in the degradation of beta2-microglobulin in acidic urine","volume":"38","author":"Yamamoto","year":"2000","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00644546","article-title":"Quantitative distribution of lysosomal hydrolases in the rat nephron","volume":"63","author":"Le Hir","year":"1979","journal-title":"Histochemistry"},{"key":"10.1016\/j.bcp.2019.113664_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2016.04.012","article-title":"Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin","volume":"303","author":"Gautier","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2016.09.003","article-title":"Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression","volume":"91","author":"Hsu","year":"2017","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.bcp.2019.113664_b0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ndt\/18.3.543","article-title":"Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit","volume":"18","author":"Westhuyzen","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0009-8981(85)90274-8","article-title":"Inhibition of A and B N-acetyl-beta-D-glucosaminidase urinary isoenzymes by urea","volume":"149","author":"Bondiou","year":"1985","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0085","doi-asserted-by":"crossref","first-page":"F517","DOI":"10.1152\/ajprenal.00291.2005","article-title":"Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury","volume":"290","author":"Vaidya","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2019.113664_b0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/emm.1998.24","article-title":"Urinary N-acetyl-beta-D-glucosaminidase in rheumatoid arthritis","volume":"30","author":"Iqbal","year":"1998","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1081\/JDI-120002662","article-title":"Increased urinary excretion of N-acetylglucosaminidase in subjects with impaired glucose tolerance","volume":"24","author":"Fujita","year":"2002","journal-title":"Ren. Fail."},{"issue":"8","key":"10.1016\/j.bcp.2019.113664_b0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1055\/s-2007-1009256","article-title":"Urinary N-acetyl-beta-D-glucosaminidase in the patients with hyperthyroidism","volume":"21","author":"Tominaga","year":"1989","journal-title":"Horm. Metab. Res."},{"issue":"10","key":"10.1016\/j.bcp.2019.113664_b0105","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","article-title":"Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury","volume":"14","author":"Mishra","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"14","key":"10.1016\/j.bcp.2019.113664_b0110","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","article-title":"Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase","volume":"268","author":"Kjeldsen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.113664_b0115","doi-asserted-by":"crossref","first-page":"12973","DOI":"10.1038\/ncomms12973","article-title":"Disposal of iron by a mutant form of lipocalin 2","volume":"7","author":"Barasch","year":"2016","journal-title":"Nat. Commun."},{"issue":"7019","key":"10.1016\/j.bcp.2019.113664_b0120","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03104","article-title":"Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron","volume":"432","author":"Flo","year":"2004","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bcp.2019.113664_b0125","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1172\/JCI42004","article-title":"Lipocalin 2 is essential for chronic kidney disease progression in mice and humans","volume":"120","author":"Viau","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/geno.1997.4896","article-title":"Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans","volume":"45","author":"Cowland","year":"1997","journal-title":"Genomics"},{"issue":"10","key":"10.1016\/j.bcp.2019.113664_b0135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.ki.5002165","article-title":"Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage","volume":"71","author":"Mori","year":"2007","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bcp.2019.113664_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129279","article-title":"Neutrophil gelatinase associated lipocalin is an early and accurate biomarker of graft function and tissue regeneration in kidney transplantation from extended criteria donors","volume":"10","author":"Cantaluppi","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2019.113664_b0145","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00431-017-2907-y","article-title":"Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury","volume":"176","author":"Westhoff","year":"2017","journal-title":"Eur. J. Pediatr."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0150","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/COC.0000000000000301","article-title":"Retrospective analysis of cisplatin nephrotoxicity in patients with head and neck cancer receiving outpatient treatment with concurrent high-dose cisplatin and radiotherapy","volume":"41","author":"Faig","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2019.113664_b0155","doi-asserted-by":"crossref","first-page":"F505","DOI":"10.1152\/ajprenal.90545.2008","article-title":"The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity","volume":"296","author":"Pabla","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"9","key":"10.1016\/j.bcp.2019.113664_b0160","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0165","doi-asserted-by":"crossref","first-page":"c154","DOI":"10.1159\/000312879","article-title":"Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study","volume":"115","author":"Gaspari","year":"2010","journal-title":"Nephron. Clin. Pract."},{"issue":"10","key":"10.1016\/j.bcp.2019.113664_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26538","article-title":"Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy","volume":"64","author":"Sterling","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0175","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/cpt.606","article-title":"Profiling of kidney injury biomarkers in patients receiving cisplatin: time-dependent changes in the absence of clinical nephrotoxicity","volume":"101","author":"George","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2019.113664_b0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tox.2016.06.011","article-title":"Early prediction of cisplatin-induced nephrotoxicity by urinary vanin-1 in patients with urothelial carcinoma","volume":"359\u2013360","author":"Hosohata","year":"2016","journal-title":"Toxicology"},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0185","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00280-015-2880-y","article-title":"Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients","volume":"76","author":"Shinke","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2019.113664_b0190","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/0306-3623(95)00049-6","article-title":"Gentamicin nephrotoxicity in humans and animals: some recent research","volume":"26","author":"Ali","year":"1995","journal-title":"Gen. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2019.113664_b0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.taap.2004.11.024","article-title":"Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria","volume":"206","author":"Servais","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2019.113664_b0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.toxrep.2018.11.015","article-title":"Gentamicin induced acute renal damage and its evaluation using urinary biomarkers in rats","volume":"6","author":"Udupa","year":"2019","journal-title":"Toxicol. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0205","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2131\/jts.42.629","article-title":"Usefulness of urinary biomarkers for nephrotoxicity in cynomolgus monkeys treated with gentamicin, cisplatin, and puromycin aminonucleoside","volume":"42","author":"Uchino","year":"2017","journal-title":"J. Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2019.113664_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043809","article-title":"Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study","volume":"7","author":"McWilliam","year":"2012","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.bcp.2019.113664_b0215","first-page":"4203","article-title":"Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as early biomarkers for predicting vancomycin-associated acute kidney injury: a prospective study","volume":"21","author":"Pang","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0220","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pharmthera.2006.04.006","article-title":"An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients","volume":"112","author":"Masuda","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5050050","article-title":"Tacrolimus modulates TGF-beta signaling to induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells","volume":"5","author":"Bennett","year":"2016","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.bcp.2019.113664_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110527","article-title":"Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients","volume":"9","author":"Tsuchimoto","year":"2014","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.bcp.2019.113664_b0235","doi-asserted-by":"crossref","first-page":"21429","DOI":"10.1074\/jbc.M300287200","article-title":"Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene","volume":"278","author":"Martin","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2019.113664_b0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cccn.2004.09.001","article-title":"Fatty acid-binding proteins as plasma markers of tissue injury","volume":"352","author":"Pelsers","year":"2005","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.bcp.2019.113664_b0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145042","article-title":"Comparison of plasma and urine biomarker performance in acute kidney injury","volume":"10","author":"Schley","year":"2015","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.bcp.2019.113664_b0250","doi-asserted-by":"crossref","first-page":"15575","DOI":"10.1074\/jbc.M011623200","article-title":"Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. implications for transmembrane and intracellular transport and for protection from lipid peroxidation","volume":"276","author":"Ek-Von Mentzer","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0255","doi-asserted-by":"crossref","first-page":"G62","DOI":"10.1152\/ajpgi.00074.2003","article-title":"HNF-1alpha and endodermal transcription factors cooperatively activate Fabpl: MODY3 mutations abrogate cooperativity","volume":"285","author":"Divine","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"Pt 1","key":"10.1016\/j.bcp.2019.113664_b0260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/BJ20031340","article-title":"Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins","volume":"382","author":"Schachtrup","year":"2004","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0265","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0270-9295(03)00088-3","article-title":"Energy metabolism and cytotoxicity","volume":"23","author":"Portilla","year":"2003","journal-title":"Semin. Nephrol."},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0270","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0002-9440(10)63384-6","article-title":"Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules","volume":"165","author":"Kamijo","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.bcp.2019.113664_b0275","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1681\/ASN.2007010097","article-title":"Renal L-type fatty acid\u2013binding protein in acute ischemic injury","volume":"18","author":"Yamamoto","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.bcp.2019.113664_b0280","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ki.2014.301","article-title":"Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury","volume":"87","author":"Parr","year":"2015","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.bcp.2019.113664_b0285","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00467-017-3748-7","article-title":"Urinary biomarkers of cell cycle arrest are delayed predictors of acute kidney injury after pediatric cardiopulmonary bypass","volume":"32","author":"Dong","year":"2017","journal-title":"Pediatr. Nephrol."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0290","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1681\/ASN.2015040345","article-title":"Associations between deceased-donor urine injury biomarkers and kidney transplant outcomes","volume":"27","author":"Reese","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13054-018-2120-z","article-title":"Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units","volume":"22","author":"Naruse","year":"2018","journal-title":"Crit. Care"},{"key":"10.1016\/j.bcp.2019.113664_b0300","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12882-015-0016-6","article-title":"Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study","volume":"16","author":"Basu","year":"2015","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0305","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ki.2015.327","article-title":"Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition","volume":"89","author":"Katagiri","year":"2016","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.bcp.2019.113664_b0310","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","article-title":"Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury","volume":"273","author":"Ichimura","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2019.113664_b0315","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1128\/JVI.72.8.6621-6628.1998","article-title":"The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor","volume":"72","author":"Feigelstock","year":"1998","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0320","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/jcp.24267","article-title":"Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells?","volume":"228","author":"Lim","year":"2013","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2019.113664_b0325","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.biocel.2012.03.015","article-title":"Distinct role of matrix metalloproteinase-3 in kidney injury molecule-1 shedding by kidney proximal tubular epithelial cells","volume":"44","author":"Lim","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"10","key":"10.1016\/j.bcp.2019.113664_b0330","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1681\/ASN.2007030325","article-title":"Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region","volume":"18","author":"Zhang","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0335","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/JVI.75.2.717-725.2001","article-title":"Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1","volume":"75","author":"Silberstein","year":"2001","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.bcp.2019.113664_b0340","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1128\/JVI.03156-14","article-title":"Interaction between TIM-1 and NPC1 Is important for cellular entry of ebola virus","volume":"89","author":"Kuroda","year":"2015","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.bcp.2019.113664_b0345","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/j.ajkd.2015.06.018","article-title":"Urinary, plasma, and serum biomarkers\u2019 utility for predicting acute kidney injury associated with cardiac surgery in adults: a meta-analysis","volume":"66","author":"Ho","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0350","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3892\/br.2015.449","article-title":"Urinary kidney injury molecule-1 as an early indicator to predict contrast-induced acute kidney injury in patients with diabetes mellitus undergoing percutaneous coronary intervention","volume":"3","author":"Li","year":"2015","journal-title":"Biomed. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2019.113664_b0355","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00380-014-0538-z","article-title":"Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography","volume":"30","author":"Torregrosa","year":"2015","journal-title":"Heart Vessels"},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0360","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1253\/circj.CJ-15-0886","article-title":"Combination of urinary biomarkers improves early detection of acute kidney injury in patients with heart failure","volume":"80","author":"Yang","year":"2016","journal-title":"Circ. J."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2019.113664_b0365","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2010.04.015","article-title":"Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats","volume":"273","author":"Tonomura","year":"2010","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0370","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ki.2009.96","article-title":"A rapid urine test for early detection of kidney injury","volume":"76","author":"Vaidya","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2019.113664_b0375","doi-asserted-by":"crossref","DOI":"10.1007\/s10157-019-01765-y","article-title":"Dynamic variation of kidney injury molecule-1 mRNA and protein expression in blood and urine of renal transplant recipients: a cohort study","author":"Keshavarz Shahbaz","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.bcp.2019.113664_b0380","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/142521","article-title":"Proximal tubular injury in medullary rays is an early sign of acute tacrolimus nephrotoxicity","volume":"2015","author":"Cosner","year":"2015","journal-title":"J. Transplant."},{"key":"10.1016\/j.bcp.2019.113664_b0385","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12882-015-0011-y","article-title":"Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy","volume":"16","author":"Nogare","year":"2015","journal-title":"BMC Nephrol."},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0390","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.169.4.1485","article-title":"Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line","volume":"169","author":"Matsushima","year":"1989","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0395","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0014-5793(89)80590-3","article-title":"Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE","volume":"244","author":"Yoshimura","year":"1989","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.bcp.2019.113664_b0400","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1081\/JDI-120015673","article-title":"Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney","volume":"24","author":"Rice","year":"2002","journal-title":"Ren. Fail."},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123203","article-title":"Deficiency for the chemokine monocyte chemoattractant protein-1 aggravates tubular damage after renal ischemia\/reperfusion injury","volume":"10","author":"Stroo","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0410","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00393-016-0109-z","article-title":"Urinary MCP-1 as a biomarker for lupus nephritis: a meta-analysis","volume":"76","author":"Lee","year":"2017","journal-title":"Z. Rheumatol."},{"issue":"10","key":"10.1016\/j.bcp.2019.113664_b0415","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/bcp.13332","article-title":"Effect of a single intravenous zoledronic acid administration on biomarkers of acute kidney injury (AKI) in patients with osteoporosis: a pilot study","volume":"83","author":"Cipriani","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0420","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.athoracsur.2016.11.036","article-title":"Plasma monocyte chemotactic protein-1 is associated with acute kidney injury and death after cardiac operations","volume":"104","author":"Moledina","year":"2017","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0425","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bcp.2012.12.019","article-title":"Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity","volume":"85","author":"Nishihara","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0430","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/bj2680287","article-title":"Structure and expression of the human cystatin C gene","volume":"268","author":"Abrahamson","year":"1990","journal-title":"Biochem. J."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2019.113664_b0435","first-page":"S20","article-title":"Diagnostic value of analysis of cystatin C and protein HC in biological fluids","volume":"38","author":"Grubb","year":"1992","journal-title":"Clin. Nephrol."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0440","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/00365519609088795","article-title":"Renal handling of radiolabelled human cystatin C in the rat","volume":"56","author":"Tenstad","year":"1996","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0445","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2004-817933","article-title":"Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy","volume":"112","author":"Aksun","year":"2004","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"3","key":"10.1016\/j.bcp.2019.113664_b0450","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1523-1755.2004.00861.x","article-title":"Early detection of acute renal failure by serum cystatin C","volume":"66","author":"Herget-Rosenthal","year":"2004","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0455","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0b013e31803bcfd2","article-title":"Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function","volume":"29","author":"Tanaka","year":"2007","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0460","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12882-017-0539-0","article-title":"Accuracy of cystatin C in prediction of acute kidney injury in children; serum or urine levels: which one works better? a systematic review and meta-analysis","volume":"18","author":"Nakhjavan-Shahraki","year":"2017","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1016\/j.bcp.2019.113664_b0465","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1159\/000485341","article-title":"Serum cystatin C predicts AKI and the prognosis of patients in coronary care unit: a prospective, observational study","volume":"42","author":"Hu","year":"2017","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.bcp.2019.113664_b0470","doi-asserted-by":"crossref","first-page":"329","DOI":"10.12659\/AOT.896700","article-title":"Comparison of cystatin C and NGAL in early diagnosis of acute kidney injury after heart transplantation","volume":"21","author":"Hoskova","year":"2016","journal-title":"Ann. Transplant"},{"issue":"7","key":"10.1016\/j.bcp.2019.113664_b0475","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/clinchem\/48.7.1123","article-title":"Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations","volume":"48","author":"Bokenkamp","year":"2002","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0480","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF03347201","article-title":"Thyroid function differently affects serum cystatin C and creatinine concentrations","volume":"28","author":"Manetti","year":"2005","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0485","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000469715","article-title":"Dexamethasone modifies cystatin c-based diagnosis of acute kidney injury during cisplatin-based chemotherapy","volume":"42","author":"Pianta","year":"2017","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0490","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10157-018-1545-7","article-title":"Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD)","volume":"22","author":"Makabe","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0495","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4037\/aacnacc2016953","article-title":"Drug-induced liver injury","volume":"27","author":"Hamilton","year":"2016","journal-title":"AACN Adv. Crit. Care"},{"issue":"12","key":"10.1016\/j.bcp.2019.113664_b0500","first-page":"767","article-title":"Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin\/clavulanic","volume":"107","author":"Moreno","year":"2015","journal-title":"Rev. Esp. Enferm. Dig."},{"issue":"6","key":"10.1016\/j.bcp.2019.113664_b0505","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0510","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.29283","article-title":"Death and liver transplantation within 2 years of onset of drug-induced liver injury","volume":"66","author":"Hayashi","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0515","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1517\/14740338.2016.1160057","article-title":"Recent advances in biomarkers and therapeutic interventions for hepatic drug safety \u2013 false dawn or new horizon?","volume":"15","author":"Clarke","year":"2016","journal-title":"Expert Opin. Drug Safety"},{"issue":"4","key":"10.1016\/j.bcp.2019.113664_b0520","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI59755","article-title":"The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation","volume":"122","author":"McGill","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0525","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/toxsci\/kft009","article-title":"Assessment of emerging biomarkers of liver injury in human subjects","volume":"132","author":"Schomaker","year":"2013","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0530","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/1354750X.2016.1269131","article-title":"A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat","volume":"22","author":"Thulin","year":"2017","journal-title":"Biomarkers"},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0535","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000370212","article-title":"Glutamate dehydrogenase and alkaline phosphatase as very early predictors of hepatocellular carcinoma recurrence after liver transplantation","volume":"91","author":"Piras-Straub","year":"2015","journal-title":"Digestion"},{"issue":"43","key":"10.1016\/j.bcp.2019.113664_b0540","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","article-title":"The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system","volume":"270","author":"Hori","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0545","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI76887","article-title":"The HMGB1\/RAGE axis triggers neutrophil-mediated injury amplification following necrosis","volume":"125","author":"Huebener","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bcp.2019.113664_b0550","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1189\/jlb.1212662","article-title":"The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis","volume":"93","author":"Yang","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0555","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jat.3002","article-title":"Involvement of immune- and inflammatory-related factors in flucloxacillin-induced liver injury in mice","volume":"35","author":"Takai","year":"2015","journal-title":"J. Appl. Toxicol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0560","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.29802","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: an international collaborative effort","volume":"69","author":"Church","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0565","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S2468-1253(17)30266-2","article-title":"Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies","volume":"3","author":"Dear","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0570","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.advms.2016.05.001","article-title":"New potential biomarkers of acetaminophen-induced hepatotoxicity","volume":"61","author":"Siemionow","year":"2016","journal-title":"Adv. Med. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2019.113664_b0575","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/liv.13441","article-title":"The transformation in biomarker detection and management of drug-induced liver injury","volume":"37","author":"Church","year":"2017","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0580","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/toxsci\/kfp235","article-title":"High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo","volume":"112","author":"Antoine","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0585","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jhep.2011.12.019","article-title":"Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity","volume":"56","author":"Antoine","year":"2012","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.bcp.2019.113664_b0590","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0595","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/toxsci\/kfu232","article-title":"Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury","volume":"143","author":"Krauskopf","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2019.113664_b0600","article-title":"A novel microRNA signature for cholestatic drugs in human hepatocytes and its translation into novel circulating biomarkers for drug-induced liver injury patients","author":"Lopez-Riera","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2019.113664_b0605","doi-asserted-by":"crossref","first-page":"15501","DOI":"10.1038\/srep15501","article-title":"Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury","volume":"5","author":"Vliegenthart","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0610","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.taap.2015.02.013","article-title":"Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children","volume":"284","author":"Yang","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0615","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13287-018-0910-5","article-title":"Inhibition of the RhoGTPase Cdc42 by ML141 enhances hepatocyte differentiation from human adipose-derived mesenchymal stem cells via the Wnt5a\/PI3K\/miR-122 pathway: impact of the age of the donor","volume":"9","author":"Chaker","year":"2018","journal-title":"Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0620","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2019.113664_b0625","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mito.2016.10.005","article-title":"Drug induced mitochondrial dysfunction: Mechanisms and adverse clinical consequences","volume":"31","author":"Vuda","year":"2016","journal-title":"Mitochondrion"},{"issue":"6","key":"10.1016\/j.bcp.2019.113664_b0630","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1074\/mcp.M800377-MCP200","article-title":"Differential permeabilization effects of Ca2+ and valinomycin on the inner and outer mitochondrial membranes as revealed by proteomics analysis of proteins released from mitochondria","volume":"8","author":"Yamada","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0635","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.dmpk.2015.11.005","article-title":"Characterization of release profile of ornithine carbamoyltransferase from primary rat hepatocytes treated with hepatotoxic drugs: Implications for its unique potential as a drug-induced liver injury biomarker","volume":"31","author":"Furihata","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.bcp.2019.113664_b0640","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1177\/0961203318788167","article-title":"Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis","volume":"27","author":"Ding","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.bcp.2019.113664_b0645","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jcrc.2017.03.029","article-title":"Novel urinary biomarkers and the early detection of acute kidney injury after open cardiac surgeries","volume":"40","author":"Elmedany","year":"2017","journal-title":"J. Crit. Care"},{"issue":"12","key":"10.1016\/j.bcp.2019.113664_b0650","first-page":"2079","article-title":"Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis","volume":"32","author":"Siwy","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/j.bcp.2019.113664_b0655","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1681\/ASN.2014050423","article-title":"Diagnosis and prediction of CKD progression by assessment of urinary peptides","volume":"26","author":"Schanstra","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcp.2019.113664_b0660","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jprot.2016.07.019","article-title":"Proteome analysis of acute kidney injury \u2013 discovery of new predominantly renal candidates for biomarker of kidney disease","volume":"151","author":"Malagrino","year":"2017","journal-title":"J. Proteomics"},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0665","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/liv.13174","article-title":"Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury","volume":"37","author":"Mikus","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.bcp.2019.113664_b0670","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3389\/fphar.2018.00699","article-title":"Proteomics analysis of monocyte-derived hepatocyte-like cells identifies integrin beta 3 as a specific biomarker for drug-induced liver injury by diclofenac","volume":"9","author":"Dragoi","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0675","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nbt0510-436","article-title":"Next-generation biomarkers for detecting kidney toxicity","volume":"28","author":"Bonventre","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.bcp.2019.113664_b0680","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1515\/cclm-2016-0973","article-title":"Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption","volume":"55","author":"Kashani","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0685","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/FTD.0000000000000589","article-title":"Biomarkers of drug-induced kidney toxicity","volume":"41","author":"Griffin","year":"2019","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0690","first-page":"214","article-title":"Combined therapy with melatonin and exendin-4 effectively attenuated the deterioration of renal function in rat cardiorenal syndrome","volume":"9","author":"Chen","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0695","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1623","article-title":"Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies","volume":"28","author":"Vaidya","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.bcp.2019.113664_b0700","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1177\/0192623314524489","article-title":"Comparison between male and female Sprague-Dawley rats in the response of urinary biomarkers to injury induced by gentamicin","volume":"42","author":"Gautier","year":"2014","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0705","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1442-200x.2004.01958.x","article-title":"Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children","volume":"46","author":"Ikarashi","year":"2004","journal-title":"Pediatr. Int."},{"issue":"1","key":"10.1016\/j.bcp.2019.113664_b0710","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00296257","article-title":"Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity","volume":"19","author":"Goren","year":"1987","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2019.113664_b0715","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2009.08.021","article-title":"Differential roles of dihydropyridine calcium antagonist nifedipine, nitrendipine and amlodipine on gentamicin-induced renal tubular toxicity in rats","volume":"620","author":"Li","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2019.113664_b0720","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/gut.38.3.414","article-title":"Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases","volume":"38","author":"Nielsen","year":"1996","journal-title":"Gut"},{"issue":"24","key":"10.1016\/j.bcp.2019.113664_b0725","doi-asserted-by":"crossref","first-page":"18345","DOI":"10.1016\/S0021-9258(17)46851-7","article-title":"Use of transgenic mice to map cis-acting elements in the liver fatty acid-binding protein gene (Fabpl) that regulate its cell lineage-specific, differentiation-dependent, and spatial patterns of expression in the gut epithelium and in the liver acinus","volume":"268","author":"Simon","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0730","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1159\/000458737","article-title":"Kidney injury molecule-1 is elevated in nephropathy and mediates macrophage activation via the mapk signalling pathway","volume":"41","author":"Tian","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0735","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cyto.2015.08.002","article-title":"T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?","volume":"76","author":"Kalavrizioti","year":"2015","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.bcp.2019.113664_b0740","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.26294","article-title":"Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital","volume":"58","author":"Antoine","year":"2013","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.bcp.2019.113664_b0745","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.bcp.2019.113664_b0750","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.24538","article-title":"Circulating microRNAs as potential markers of human drug-induced liver injury","volume":"54","author":"Starkey Lewis","year":"2011","journal-title":"Hepatology"},{"issue":"29","key":"10.1016\/j.bcp.2019.113664_b0755","doi-asserted-by":"crossref","first-page":"26792","DOI":"10.1074\/jbc.M103315200","article-title":"Effect of mutation and phosphorylation of type I keratins on their caspase-mediated degradation","volume":"276","author":"Ku","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2019.113664_b0760","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2006.06.018","article-title":"Advantage of serum type-I arginase and ornithine carbamoyltransferase in the evaluation of acute and chronic liver damage induced by thioacetamide in rats","volume":"375","author":"Murayama","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.bcp.2019.113664_b0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136994","article-title":"Molecular markers of tubulointerstitial fibrosis and tubular cell damage in patients with chronic kidney disease","volume":"10","author":"Nakagawa","year":"2015","journal-title":"PLoS One"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219303636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219303636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:06:24Z","timestamp":1757768784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219303636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":153,"alternative-id":["S0006295219303636"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113664","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical prospects of biomarkers for the early detection and\/or prediction of organ injury associated with pharmacotherapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113664"}}